141 related articles for article (PubMed ID: 15113587)
1. Prostanoids in the cutaneous immune response.
Kabashima K; Miyachi Y
J Dermatol Sci; 2004 May; 34(3):177-84. PubMed ID: 15113587
[TBL] [Abstract][Full Text] [Related]
2. Prostanoids in allergy.
Honda T; Kabashima K
Allergol Int; 2015 Jan; 64(1):11-6. PubMed ID: 25572554
[TBL] [Abstract][Full Text] [Related]
3. Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.
Yuhki K; Kojima F; Kashiwagi H; Kawabe J; Fujino T; Narumiya S; Ushikubi F
Pharmacol Ther; 2011 Feb; 129(2):195-205. PubMed ID: 20920529
[TBL] [Abstract][Full Text] [Related]
4. Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology.
Honda T; Tokura Y; Miyachi Y; Kabashima K
Curr Drug Targets; 2010 Dec; 11(12):1605-13. PubMed ID: 20735353
[TBL] [Abstract][Full Text] [Related]
5. Function of prostanoid receptors: studies on knockout mice.
Kobayashi T; Narumiya S
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():557-73. PubMed ID: 12432943
[TBL] [Abstract][Full Text] [Related]
6. The potential of selected prostanoid receptors as targets in a new therapeutic strategy for allergy and immune diseases.
Kabashima K; Tokura Y
Curr Drug Saf; 2007 Sep; 2(3):186-92. PubMed ID: 18690966
[TBL] [Abstract][Full Text] [Related]
7. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.
Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S
Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157
[TBL] [Abstract][Full Text] [Related]
8. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
9. Prostanoid receptors and the urogenital tract.
Breyer MD; Hébert RL; Breyer RM
Curr Opin Investig Drugs; 2003 Nov; 4(11):1343-53. PubMed ID: 14758774
[TBL] [Abstract][Full Text] [Related]
10. Prostanoids as regulators of innate and adaptive immunity.
Hirata T; Narumiya S
Adv Immunol; 2012; 116():143-74. PubMed ID: 23063076
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins in the kidney: developments since Y2K.
Nasrallah R; Clark J; Hébert RL
Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
[TBL] [Abstract][Full Text] [Related]
12. Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis.
Honda T; Kabashima K
Int Immunol; 2019 Aug; 31(9):589-595. PubMed ID: 30715370
[TBL] [Abstract][Full Text] [Related]
13. Immune mechanisms leading to atopic dermatitis.
Novak N; Bieber T; Leung DY
J Allergy Clin Immunol; 2003 Dec; 112(6 Suppl):S128-39. PubMed ID: 14657843
[TBL] [Abstract][Full Text] [Related]
14. The role of human beta defensins and cathelicidins in atopic dermatitis.
Howell MD
Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):413-7. PubMed ID: 17873581
[TBL] [Abstract][Full Text] [Related]
15. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of infections in atopic dermatitis.
Biedermann T
Acta Derm Venereol; 2006; 86(2):99-109. PubMed ID: 16648910
[TBL] [Abstract][Full Text] [Related]
17. The immune system and atopic dermatitis.
Dokmeci E; Herrick CA
Semin Cutan Med Surg; 2008 Jun; 27(2):138-43. PubMed ID: 18620135
[TBL] [Abstract][Full Text] [Related]
18. Physiology and pathophysiology of prostanoid receptors.
Narumiya S
Proc Jpn Acad Ser B Phys Biol Sci; 2007 Dec; 83(9-10):296-319. PubMed ID: 24367153
[TBL] [Abstract][Full Text] [Related]
19. Exploring the roles of prostanoids, leukotriens, and dietary fatty acids in cutaneous inflammatory diseases: Insights from pharmacological and genetic approaches.
Honda T; Kabashima K; Kunisawa J
Immunol Rev; 2023 Aug; 317(1):95-112. PubMed ID: 36815685
[TBL] [Abstract][Full Text] [Related]
20. Prostanoids and inflammation: a new concept arising from receptor knockout mice.
Narumiya S
J Mol Med (Berl); 2009 Oct; 87(10):1015-22. PubMed ID: 19609495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
